Dr. Agrawals Eye Hospital Share Price | Dr. Agrawals Eye Hospital Stock Screener
DRAGARWQ
Hospitals
Share Price NSE
₹5091.90
▼
-32.20 (-0.63%)
Share Price BSE
₹5110.00
▼
-9.20 (-0.18%)
As of May 27, 2026, the Dr. Agrawals Eye Hospital share price (NSE: DRAGARWQ) is ₹5,091.90 on NSE and ₹5,110.00 on BSE, down 0.63% from the previous close, with shares trading between ₹5,005.00 and ₹5,182.90, and a 52-week range of ₹4,787.85–₹5,174.80.
Check Dr. Agrawals Eye Hospital 52-week for the annual price range and momentum.
Use the Dr. Agrawals Eye Hospital stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Dr. Agrawals Eye Hospital Market Cap
₹2,476.44 Cr.
DRAGARWQ P/E Ratio (TTM)
35.51
Dr. Agrawals Eye Hospital P/B Ratio
7.19
EPS (TTM)
₹147.02
Dividend Yield
-
Debt to Equity
1.64
DRAGARWQ 52 Week High
₹5174.80
Dr. Agrawals Eye Hospital 52 Week Low
₹4787.85
Operating Margin
31.00%
Profit Margin
14.86%
DRAGARWQ Revenue (TTM)
₹471.00
EBITDA
₹145.00
Net Income
₹70.00
Total Assets
₹767.00
Total Equity
₹346.00
Dr. Agrawals Eye Hospital Share Price Chart
Screen Dr. Agrawals Eye Hospital share price with an interactive chart. Analyse DRAGARWQ price trends and volatility across different timeframes.
Dr. Agrawals Eye Hospital Company Profile - Fundamental Screener
Screen Dr. Agrawals Eye Hospital company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for DRAGARWQ shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE934C01018
Dr. Agrawals Eye Hospital Balance Sheet Screener
Screen DRAGARWQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 767 | 613 | 496 | 390 | 314 | 155 | 141 | 100 | 81 | 72 |
| Current Assets | 137 | 56 | 60 | 47 | 50 | 44 | 30 | 30 | 23 | 20 |
| Fixed Assets | 600 | 393 | 316 | 260 | 214 | 96 | 94 | 55 | 36 | 33 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 309 | 317 | 258 | 222 | 183 | 52 | 45 | 19 | 9 | 16 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 346 | 210 | 157 | 113 | 78 | 55 | 56 | 46 | 35 | 29 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 342 | 205 | 152 | 109 | 74 | 50 | 51 | 41 | 30 | 25 |
Dr. Agrawals Eye Hospital Income Statement Screener - Profit & Revenue Analysis
Screen Dr. Agrawals Eye Hospital income statement and profit fundamentals.
Analyze DRAGARWQ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Dr. Agrawals Eye Hospital share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 471 | 402 | 324 | 270 | 203 | 141 | 179 | 172 | 156 | 150 | 137 | 118 |
| Expenses | 326 | 279 | 228 | 193 | 144 | 109 | 130 | 141 | 130 | 127 | 120 | 104 |
| EBITDA | 145 | 124 | 96 | 77 | 59 | 31 | 49 | 31 | 26 | 23 | 17 | 15 |
| Operating Profit % | 31.00% | 30.00% | 29.00% | 28.00% | 29.00% | 22.00% | 26.00% | 17.00% | 15.00% | 14.00% | 12.00% | 12.00% |
| Depreciation | 46 | 40 | 27 | 20 | 20 | 19 | 21 | 11 | 10 | 9 | 9 | 6 |
| Interest | 12 | 13 | 7 | 7 | 6 | 6 | 8 | 3 | 3 | 3 | 4 | 3 |
| Profit Before Tax | 94 | 71 | 62 | 49 | 32 | 6 | 20 | 17 | 13 | 11 | -1 | 5 |
| Tax | 23 | 16 | 16 | 13 | 8 | 7 | 6 | 6 | 7 | 4 | -1 | 0 |
| Net Profit | 70 | 55 | 46 | 37 | 24 | -1 | 14 | 12 | 7 | 7 | 0 | 6 |
| EPS | 147.02 | 116.28 | 98.64 | 78.55 | 51.28 | -3.06 | 29.11 | 25.35 | 14.42 | 15.61 | 0.08 | 12.12 |
Dr. Agrawals Eye Hospital Cash Flow Screener - Liquidity Fundamentals
Screen DRAGARWQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 95 | 90 | 70 | 57 | 34 | 39 | 25 | 19 | 20 | 17 |
| Investing Activities | -133 | -70 | -71 | -46 | -11 | -17 | -25 | -11 | -8 | -17 |
| Financing Activities | 17 | -14 | 0 | -4 | -8 | -20 | 2 | -8 | -12 | 0 |
| Net Cash Flow | -22 | 6 | -1 | 7 | 15 | 2 | 2 | -1 | 0 | 0 |
Dr. Agrawals Eye Hospital Shareholding Pattern Screener
See Dr. Agrawals Eye Hospital shareholding pattern with promoter, FII, and DII holdings.
Check Dr. Agrawals Eye Hospital promoter holding and ownership changes for DRAGARWQ on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.67% | 71.90% | 71.90% | 72.67% | 72.67% | 71.90% | 71.90% | 71.90% |
| FII Holding | 2.20% | 1.33% | 1.50% | 1.74% | 1.82% | 0.64% | 0.65% | 0.83% |
| DII Holding | 2.12% | 1.95% | 2.31% | 2.36% | 2.36% | 0.00% | 0.00% | 0.96% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 17.93% | 19.25% | 18.95% | 18.17% | 17.96% | 21.74% | 21.77% | 20.51% |
| Other Holding | 5.07% | 5.57% | 5.34% | 5.06% | 5.19% | 5.72% | 5.69% | 5.80% |
| Shareholder Count | 24,036 | 41,704 | 35,976 | 30,528 | 25,449 | 3,572 | 3,808 | 4,510 |
Dr. Agrawals Eye Hospital Share Dividend Screener - Share Yield Analysis
Check Dr. Agrawals Eye Hospital dividend history with payout and yield data.
View Dr. Agrawals Eye Hospital dividend details including ex-dates and amounts for DRAGARWQ stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹6.00 | 0.13% |
| 2024-March | ₹2.50 | 0.06% |
| 2023-March | ₹3.00 | 0.10% |
| 2022-March | ₹3.00 | 0.33% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.50 | 0.79% |
| 2018-March | ₹1.20 | 0.33% |
| 2017-March | ₹1.50 | 0.25% |
Dr. Agrawals Eye Hospital Stock Index Membership
See which indices include Dr. Agrawals Eye Hospital stock.
Check DRAGARWQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Dr. Agrawals Eye Hospital Market Events Screener - Corporate Actions
Get Dr. Agrawals Eye Hospital corporate actions including splits, bonuses, and buybacks.
Check Dr. Agrawals Eye Hospital stock events that may affect DRAGARWQ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 3.50 /share | 6.35% | ||
| Dividend | ₹ 3.00 /share | 105.12% | ||
| Dividend | ₹ 3.00 /share | 46.51% | ||
| Annual General Meeting | NA | -7.76% | ||
| 2026-05-20 | 2026-05-20 | Quarterly Result Announcement | NA | 0.41% |
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | -0.08% |
| 2025-11-07 | 2025-11-07 | Dividend | ₹ 3.00 /share | 2.42% |
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | -3.36% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 0.71% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 2.34% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -4.87% |
| 2024-11-08 | 2024-11-08 | Dividend | ₹ 2.50 /share | 0.26% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -1.55% |
| 2024-08-26 | 2024-08-26 | Annual General Meeting | NA | 0.11% |
| 2024-08-19 | 2024-08-20 | Dividend | ₹ 2.50 /share | 14.07% |
Dr. Agrawals Eye Hospital Competitors Screener - Peer Comparison
Screen DRAGARWQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 120,937 | 60.02 | 25,229 | 14.70% | 2,032 | 72.11 |
| Max Healthcare Institute | 98,141 | 69.05 | 8,373 | 16.56% | 1,464 | 49.03 |
| Fortis Healthcare | 73,054 | 73.94 | 9,128 | 16.28% | 1,064 | 58.34 |
| Narayana Hrudayalaya | 39,534 | 48.63 | 7,896 | 41.63% | 788 | 54.08 |
| Aster DM Healthcare | 39,066 | 91.78 | 4,643 | 8.32% | 384 | 63.54 |
| Global Health | 33,478 | 60.09 | 4,410 | 16.94% | 584 | 65.94 |
| Krishna Institute of Medical Sciences | 30,565 | 126.29 | 3,905 | 27.31% | 198 | 61.12 |
| Dr. Agarwal's Health Care | 15,139 | 90.43 | 2,080 | 18.39% | 168 | 65.11 |
| Rainbow Childrens Medicare | 13,486 | 52.98 | 1,567 | 17.46% | 244 | 66.76 |
| Park Medi World | 11,549 | 40.99 | 1,679 | 17.77% | 272 | 67.30 |
Dr. Agrawals Eye Hospital Company Announcements - News Screener
Screen DRAGARWQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-25 | Corporate Action-Board approves Dividend | - |
| 2026-05-25 | Board Meeting Outcome for Consideration And Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2026 And Declaration Of Final Dividend For The Financial Year Ended March 31 2026 | - |
| 2026-05-25 | Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-19 | Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-11 | Receipt Of Order Passed By The HonBle NCLT In Relation To The Scheme Of Amalgamation Between Dr. AgarwalS Eye Hospital Limited And Dr. AgarwalS Health Care Limited | - |
| 2026-04-21 | Trading And Admission To Dealings Of The CompanyS Equity Shares On The National Stock Exchange Of India Limited | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-02-23 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Change in Registered Office Address | - |
| 2026-02-03 | Results- Financial Results For The Quarter And Nine Months Ended December 31 2025 | - |
| 2026-02-03 | Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 | - |
| 2026-01-28 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 | - |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-26 | Closure of Trading Window | - |
| 2025-10-30 | Corporate Action-Board approves Dividend | - |
| 2025-10-30 | Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | - |
| 2025-10-30 | Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 And Declaration Of Interim Dividend | - |
| 2025-10-27 | Corporate Action - Fixes Record Date As November 07 2025 For The Purpose Of Interim Dividend If Declared By The Board | - |